Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablet
Recalled March 26, 2025 · FDA recall D-0291-2025 · Mylan Institutional
Hazard
Super-Potent Drug: Out of specification potency results were obtained. · FDA Class II
Units
1,068 cartons
Sold at
Nationwide in the USA
Description
Super-Potent Drug: Out of specification potency results were obtained.
Product
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.
Manufacturer(s)
Mylan Institutional, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →